Skip to main content
Log in

Developmental patterns of serum 3α-androstanediol glucuronide

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

3α-androstanediol glucuronide (3αdiolG) is a marker of peripheral tissue androgen metabolism. There are no previous data regarding complete paediatric reference ranges for 3αdiolG. In order to obtain reference values for 3αdiolG we have measured serum levels of 3αdiolG in 283 healthy children and adolescents, 146 boys and 137 girls, age 1 month to 20 years and 28 adults. A non-extraction, solid phase radioimmunoassay employing a polyclonal antiserum that is specific for 3αdiolG was used to measure serum 3αdiolG levels (intra assay variation 5.1–10.1%, inter assay variation 2.7–9.0%). There was a strong sex and age dependence (r=0.8; p<0.0001) of 3αdiolG levels throughout childhood and adolescence with males showing significantly higher levels of the androgen than females (p<0.05). 3αdiolG serum levels (nmol/l±SD) correlated significantly with pubertal stage (p<0.01). Interestingly, in 35 children with CAH serum 3αdiolG levels correlated well with clinical and metabolic status, i.e. 170HP serum levels. In summary, we have established percentile curves for 3αdiolG levels in healthy children and adolescents. We hypothesize that on the basis of our reference values the single measurement of serum 3αdiolG could serve as a means to determine androgen status in children with disorders of puberty and sexual development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Morimoto I., Edmiston A., Hawks D., Horton R. Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men. J. Clin. Endocrinol. Metab. 52: 112, 1981.

    Google Scholar 

  2. Moghissi E., Ablan F., Horton R. Origin of plasma androstanediol glucuronide in men. J. Clin. Endocrinol. Metab. 59: 417, 1984.

    Article  PubMed  CAS  Google Scholar 

  3. Vermeulen A., Giagulli V.A. Physiology of plasma androstanediol glucuronide. J. Ster. Biochem. Mol. Biol. 39: 829, 1991.

    Article  CAS  Google Scholar 

  4. Rittmaster R.S. Androgen conjugates: Physiology and clinical significance. Endocr. Rev. 14: 121, 1993.

    Article  PubMed  CAS  Google Scholar 

  5. Narang R., Rao J., Savjani G., Petersen J. Radioimmunoassay kit for the quantitative measurement of serum androstanediol glucuronide in unextracted serum. Clin. Chem. 37: 1049A, 1991.

    Google Scholar 

  6. Andre M., Valsamis J. Reference values for androstanediol glucuronide. Clin. Chem. 40: 162, 1994.

    PubMed  CAS  Google Scholar 

  7. Schnakenburg v K., Bidlingmaier F., Knorr D. 17OHprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia. Eur. J. Pediatr. 133: 259, 1980.

    Article  Google Scholar 

  8. Pang S., MacGillivray M., Wang M., Jeffries S., Clark A., Rosenthal I. 3-androstandediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion. J. Clin. Endocrinol. Metab. 73: 166, 1991.

    Article  PubMed  CAS  Google Scholar 

  9. Hatun S., Yordum N., Calikoglu A.S. Serum 3-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia. Eur. J. Endocrinol. 131: 504, 1994.

    Article  PubMed  CAS  Google Scholar 

  10. Wudy S.A., Wächter U.A., Homoki J., Teller W.M. 5a-androstane-3, 17β-diol and 5α-androstane-3α, 17β-diol glucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study. Eur. J. Endocrinol. 134: 87, 1996.

    Article  PubMed  CAS  Google Scholar 

  11. Meikle A.W., Odell W.D.: Effect of short- and long-term dexamethasone on 3α-androstanediol glucuronide in hirsute women. Fertil Steril 46: 227, 1986.

    PubMed  CAS  Google Scholar 

  12. Horton R., Hawks D., Lobe R. 3a, 17β-Androstanediol glucuronide in plasma: a marker of androgen action in idiopathic hirsutism. J. Clin. Invest. 69: 1203, 1982.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  13. Paulson R.J., Serafini P.C., Catalino J.A., Lobo R.A. Measurements of 3α,17β-androstanediol glucuronide in serum and urine and correlation with skin 5α-re-ductase activity. Fertil. Steril. 46: 222, 1986.

    PubMed  CAS  Google Scholar 

  14. Lobo R.A., Shoupe D., Serafini P., Brinton D., Horton H. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil. Steril. 43: 200, 1985.

    PubMed  CAS  Google Scholar 

  15. Scanlon M.J., Whorwood C.B., Franks S., Reed M.J., James V.H.T. Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction. Clin. Endocrinol. (Oxf.) 29: 529, 1988.

    Article  CAS  Google Scholar 

  16. Pang S., Wang G., Jeffries S., Riddick L., Clark A., Estrada E. Normal and elevated 3α-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels. J. Clin. Endocrinol. Metab. 75: 243, 1992.

    PubMed  CAS  Google Scholar 

  17. Riddick L., Garibaldi L., Wang M., Senne A.R., Klimah P.E., Clark A.T. 3α-androstanediol glucuronide in premature and normal pubarche. J. Clin. Endocrinol. Metab. 72: 46, 1991.

    Article  PubMed  CAS  Google Scholar 

  18. Balducci R., Finocchi G., Mangiantini A., Bianchi P., Gugulielmi R., Toscane V. Plasma 3α-androstanediol glucuronide in precocious puberty. J. Endocrinol. Inves. 16: 117, 1993.

    Article  CAS  Google Scholar 

  19. Reiner B.J., Donohoue P.A., Migeon C.J., Berkovitz G.D. Serum 3α-Androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy. J. Clin. Endocrinol. Metab. 69: 105, 1989.

    Article  PubMed  CAS  Google Scholar 

  20. Gilad S., Chayen R., Tordjman K., Kisch E., Stern N. Assessment of 5α-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion. Clin. Endocrinol. (Oxf.) 40: 459, 1994.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rittner, H.L., Lee, P.D.K., Blum, W.F. et al. Developmental patterns of serum 3α-androstanediol glucuronide. J Endocrinol Invest 20, 138–143 (1997). https://doi.org/10.1007/BF03346892

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346892

Key-words

Navigation